Skip to main content
. 2023 Dec 31;44(1):127–172. doi: 10.1002/cac2.12516
Level of evidence
Category Quality of level Source CSCO expert consensus
1A High Based on data from well‐structured and rigorously controlled meta‐analyses and/or large‐scale randomized controlled clinical trials Uniform consensus (support level: ≥80%)
1B High Based on data from well‐structured and rigorously controlled meta‐analyses and/or large‐scale randomized controlled clinical trials Consensus with minimum disagreement (support level: 60%‐80%)
2A Relatively low Based on data from meta‐analysis, small‐scale randomized controlled trials, well‐designed large‐scale retrospective studies, and/or case‐control studies Uniform consensus (support level: ≥80%)
2B Relatively low Based on data from meta‐analysis, small‐scale, randomized controlled trials, well‐designed large‐scale retrospective studies, and/or case‐control studies Consensus with minimum disagreement (support level: 60%‐80%)
3 Low Based on data from single‐arm clinical studies, case reports, and/or expert opinions No consensus was reached, and had major disagreement (support level: <60%)

Abbreviation: CSCO, Chinese Society of Clinical Oncology.